Beta-blockers for congestive heart failure: what is the current consensus? (Q33873267)

29 July 2017

1 reference

title

Beta-blockers for congestive heart failure: what is the current consensus? (English)

1 reference

29 July 2017

congestive heart failure

1 reference

Tsuyuki RT

1

1 reference

29 July 2017

McAlister FA

series ordinal

2

1 reference

29 July 2017

Teo KK

series ordinal

3

1 reference

29 July 2017

1 January 2000

1 reference

29 July 2017

1 reference

29 July 2017

16

1 reference

29 July 2017

1

1 reference

29 July 2017

1-7

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200016010-00001

29 July 2017

0 references

cites work

Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00001

Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00001

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00001

Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00001

The treatment and prevention of coronary heart disease in Canada: do older patients receive efficacious therapies? The Clinical Quality Improvement Network (CQIN) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00001

The ambiguous relation between aging and adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200016010-00001

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

21 January 2018

1 reference

12 December 2020

Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo

1 reference

12 December 2020

Practical guidelines for initiation of beta-adrenergic blockade in patients with chronic heart failure

1 reference

12 December 2020

Diagnosis and management of heart failure. Canadian Cardiovascular Society

1 reference

12 December 2020

Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials

1 reference

12 December 2020

Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study

1 reference

12 December 2020

Usefulness of bucindolol in congestive heart failure

1 reference

12 December 2020

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

12 December 2020

Prevalence and mortality rate of congestive heart failure in the United States

1 reference

12 December 2020

Non invasive evaluation of cardiovascular effects of nebivolol in patients with cardiac insufficiency

1 reference

12 December 2020

Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials

1 reference

12 December 2020

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

12 December 2020

Meta-analysis of the use of low-dose beta-adrenergic blocking therapy in idiopathic or ischemic dilated cardiomyopathy

1 reference

12 December 2020

Epidemiology of heart failure

1 reference

12 December 2020

Overcoming the limitations of current meta-analysis of randomised controlled trials.

1 reference

12 December 2020

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

12 December 2020

Metabolic and cardiovascular benefits deriving from beta-adrenergic blockade in chronic congestive heart failure

1 reference

12 December 2020

Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group

1 reference

12 December 2020

Controversies surrounding the use of beta-blockers in older patients with cardiovascular disease

1 reference

12 December 2020

National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.

1 reference

12 December 2020

Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial

1 reference

12 December 2020

Survival after the onset of congestive heart failure in Framingham Heart Study subjects

1 reference

12 December 2020

Beta-blockers and depression. Evidence against an association

1 reference

12 December 2020

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

12 December 2020

Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction

1 reference

12 December 2020

The exclusion of the elderly and women from clinical trials in acute myocardial infarction

1 reference

12 December 2020

Consensus recommendations for the management of chronic heart failure

1 reference

12 December 2020

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

12 December 2020

Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy

1 reference

12 December 2020

Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy

1 reference

12 December 2020

The Natural History of Congestive Heart Failure: The Framingham Study

1 reference

12 December 2020

A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators

1 reference

12 December 2020

Improvement in exercise performance and hemodynamics by labetalol in patients with idiopathic dilated cardiomyopathy.

1 reference

12 December 2020

Neuropsychological side effects of beta-blockers

1 reference

12 December 2020

[Chronic treatment of dilated cardiomyopathy by beta blocking agents. Clinical and hemodynamic follow-up]

1 reference

12 December 2020

Beta-adrenergic blockade in chronic heart failure.

1 reference

12 December 2020

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

12 December 2020

Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials

1 reference

12 December 2020

Quality of life in cardiovascular diseases. Emphasis on beta-blocker treatment

1 reference

12 December 2020

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

1 reference

12 December 2020

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

12 December 2020

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

12 December 2020

Beta-blocker therapy for congestive heart failure: a systemic overview and critical appraisal of the published trials

1 reference

12 December 2020

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure

1 reference

12 December 2020

10.2165/00002512-200016010-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

1018311996

0 references

Fatcat ID

release_up3q325wgjcijfabqv4u7rfwcm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/up3q325wgjcijfabqv4u7rfwcm

24 November 2022

mapped directly with Wikidata item

1 reference